Xyzal Approved for Younger Kids

Font Size

10 Common Allergy Triggers Slideshow

Pets and Allergies Slideshow

Home Allergy Quiz Slideshow

Latest Allergies News

TUESDAY, Aug. 25 (HealthDay News) -- The antihistamine Xyzal (levocetirizine dihydrochloride) has been approved for children aged six months and older for indoor allergies and hives, drug makers UCB and Sanofi-Aventis said.

The medication, available as a liquid or pill, had been approved previously for people aged six years and older. The expanded approval also sanctions the drug's use to treat outdoor allergies in children aged two years and older.

Side effects of the medication may include fatigue, sore throat and dry mouth. Younger children may have additional adverse effects including fever, diarrhea, vomiting, ear infections and constipation, the drug makers said in a news release.

-- Scott Roberts

News Articles
1
2
3
4
5
Next Article: Child Food Allergies on the Rise in U.S. »

Printer-Friendly Format

Email to a Friend

Health categories:	Slideshows \| Diseases & Conditions \| Symptoms & Signs \| Procedures & Tests \| Medications \| Health & Living \| News & Views \| Medical Dictionary
Popular health centers:	Allergies \| Arthritis \| Cancer \| Diabetes \| Digestion \| Healthy Kids \| Heart \| Men's Health \| Mental Health \| Women's Health \| More...
Publications:	ePublications (PDFs) \| XML News via RSS \| Audio Podcasts \| Email Newsletters
MedicineNet.com:	About Us \| Privacy Policy \| Site Map \| WebMD® \| Medscape® \| eMedicine® \| eMedicineHealth® \| RxList®

Xyzal Approved for Younger Kids

Latest Allergies News

Allergies & Asthma

From WebMD

Allergies Resources

Featured Centers

Health Solutions From Our Sponsors

Daily Health News